NEILA RAY: Open Payments
NPI 1275269631 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 49 payments from 21 companies in 2025. Trend: 2023 $728 · 2024 $796 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $168 |
| PFIZER INC. | 11 | $136 |
| GlaxoSmithKline, LLC. | 5 | $122 |
| ABBVIE INC. | 5 | $120 |
| Novo Nordisk Inc | 4 | $91 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Merck Sharp & Dohme LLC | 3 | $45 |
| ABIOMED | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $33 |
Products named: AIRSUPRA, NURTEC ODT, SHINGRIX, GEMTESA, QULIPTA, Wegovy, VRAYLAR, PREVNAR 20.
Industry payments across CO — which companies pay providers there.
